Subject: Fwd: BHR Directorship Issues
From: "Eric Schwerin" <[email-masked]>
To: "Hunter Biden" <[email-masked]>
Date: Wed, 15 Jun 2016 16:39:50 -0400

Just FYI, this is the result of my conversation with Devon so we are making progress. 

Eric D. Schwerin
Rosemont Seneca Advisors, LLC
1010 Wisconsin Ave., NW
Suite 705
Washington, DC 20007
(202) 333-1880
[email-masked] <x-msg://59/[email-masked]>
P Consider the environment before printing this email.

> Begin forwarded message:
> 
> From: "Matthew L. Schwartz" <[email-masked]>
> Subject: RE: BHR Directorship Issues
> Date: June 15, 2016 at 4:38:31 PM EDT
> To: "Mesires, George R." <[email-masked]>
> Cc: "Eric D. Schwerin" <[email-masked]>, "Martin, George D." <[email-masked]>, Joseph Eno <[email-masked]>
> 
> George –
>  
> We should discuss this at your convenience.  I am copying in Joseph Eno of our corporate department who should be part of these discussions.
>  
> -mls
>   <>
> From: Mesires, George R. [mailto:[email-masked]] 
> Sent: Wednesday, June 8, 2016 9:19 AM
> To: Matthew L. Schwartz
> Cc: Eric D. Schwerin; Martin, George D.
> Subject: Fwd: BHR Directorship Issues
>  
> Matthew:
>  
> In connection with your addressing the shareholding issue of the BHR equity, we would like to use the opportunity to strip out Hunter's 10% interest, which I understand has been fully funded (or very close thereto) and is to come from RSB's holdings. To the extent that there is a discrepancy on the accounting of Hunter's contributions, or if there is a deficiency, we are happy to discuss our accounting as we understand it and to resolve any discrepancies that exist.
>  
> Thank you. 
>  
> George 
>  
> George R. Mesires
> Partner
> [email-masked] <mailto:[email-masked]>    Download vCard <http://www.faegrebd.com/vcard/george.mesires.vcf>
> D: +1 312 356 5101 <tel:+1%20312%20356%205101> | M: +1 312 972 4151 <tel:+1%20312%20972%204151>
> 
> Faegre Baker Daniels LLP <http://www.faegrebd.com/>
> 311 S. Wacker Drive | Suite 4300 | Chicago, IL 60606, USA <x-apple-data-detectors://2/1>
> 
> Begin forwarded message:
> 
> From: 王昕 <[email-masked] <mailto:[email-masked]>>
> Date: June 6, 2016 at 11:13:49 PM CDT
> To: "'Mesires, George R.'" <[email-masked] <mailto:[email-masked]>>, "'Matthew L. Schwartz'" <[email-masked] <mailto:[email-masked]>>, 'Michael Leonard' <[email-masked] <mailto:[email-masked]>>, 'James Bulger' <[email-masked] <mailto:[email-masked]>>, "'Eric Schwerin'" <[email-masked] <mailto:[email-masked]>>
> Cc: 'Jonathan Li' <[email-masked] <mailto:[email-masked]>>, <[email-masked] <mailto:[email-masked]>>, "'YU, Felix'" <[email-masked] <mailto:[email-masked]>>
> Subject: BHR Directorship Issues
> 
> Dear Matthew and George,
>  
> Hope all is well since we last spoke.  I am writing to follow up on the status of Devon’s resignation from BHR’s board / remuneration committee and the appointment of a replacement.
>  
> On a related note, I would also like to understand how Devon would like to deal with his shareholding in BHR through Rosemont Seneca Bohai.  By way of background, we underwent a shareholder registration amendment last year with the Chinese regulators to change Devon’s shareholding entity from RST to the existing Rosemont Seneca Bohai (the process took altogether more than a year), we were subsequently instructed earlier this year to file another amendment to change Rosemont Seneca Bohai to Ulysses (an entity owned 100% by Devon) but that has been put on hold on account of present circumstances.  From BHR’s perspective, we ask the relevant parties to consider, for the time being, a transfer by Rosemont Seneca Bohai of its shareholding to another entity (whether it is to RSP or Thornton or the management team) to avoid potential complications for our U.S. M&A deals and/or U.S. fundraising activities.  
>  
> Happy to discuss over a call.
>  
> Xin
>  
> Xin Wang 王昕
> Bohai Harvest RST (Shanghai) Equity Investment Fund Management Co., Ltd.
> 渤海华美（上海）股权投资基金管理有限公司
> Tel: +86 (10) 5969 5858 ext 816
> Cel: +86 139 1162 0708
> [email-masked] <mailto:[email-masked]>
>  
> 
> The information contained in this electronic message is confidential information intended only for the use of the named recipient(s) and may contain information that, among other protections, is the subject of attorney-client privilege, attorney work product or exempt from disclosure under applicable law. If the reader of this electronic message is not the named recipient, or the employee or agent responsible to deliver it to the named recipient, you are hereby notified that any dissemination, distribution, copying or other use of this communication is strictly prohibited and no privilege is waived. If you have received this communication in error, please immediately notify the sender by replying to this electronic message and then deleting this electronic message from your computer. [v.1]